Skip to main content
. Author manuscript; available in PMC: 2014 May 29.
Published in final edited form as: Pathophysiology. 2012 Mar 22;20(1):59–69. doi: 10.1016/j.pathophys.2012.02.003

Table 1.

Clinical Data for the Temporal Lobe Epilepsy Patients

Pt. # Age of Onset (years) Seizure frequency Epilepsy Duration (years) Follow-up (months) Surgical Outcome Seizure Focus Pathology Neuroimaging
MRI PET
1 12 1.4/day 6 0.1 SF Left TL - Left H atrophy Left TL hypometabolism
2 29 18/day 4 11 SI Right TL Focal cortical dysplasia & gliosis Right hemisphere polygyria Left TL hypometabolism
3 44 0.02/day 7 16 SF Right TL - Right medial temporal sclerosis Right TL hypometabolism
4 28 0.1/day 8 1 SF Right TL - Right H atrophy Right TL hypometabolism
5 0.5 0.3/day 31 13 I Left TL - Left medial temporal sclerosis Left TL hypometabolism
6 6 7/day 32 12 SI Left TL - Normal Normal
7 30 0.1/day 15 2 SI Left TL - Left H atrophy Left lateral and right medial TL hypometabolism
8 13 0.05/day 26 6 SI Right TL - Right H atrophy Right anterior TL hypometabolism
9 11 0.1/day 2 36 SF Left TL Amygdalar low grade ependymoma (WHO grade II) Left amygdalar minimally enhancing mass
10 30 0.1/day 10 11 SF Right TL - Right medial temporal sclerosis Right anterior/medial TL hypometabolism
11 19 1/day 22 4 SF Left TL - Left frontal lobe gliosis Left anterior TL hypometabolism
12 21 1.5/day 34 7 SF Left TL Cortical micro-calcifications Cystic lesion left medial TL
13 31 0.3/day 8 4 SI Left TL - Left medial temporal sclerosis Left TL hypometabolism

SF Seizure-free

SI Significantly

I Improved

U Unchanged

H Hippocampus

TL Temporal Lobe

No seizures

> 90% seizure frequency reduction

50-90% seizure frequency reduction

< 50% seizure frequency reduction